Skip to content

Mindfulness for Pediatric Chest Pain

Determining the Feasibility, Acceptability, and Effectiveness of a Self-Guided Mindfulness-Based Intervention in Pediatric Patients With Idiopathic Chest Pain: A Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05939492
Enrollment
20
Registered
2023-07-11
Start date
2024-03-25
Completion date
2025-03-31
Last updated
2024-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

Pediatrics, Idiopathic, Chest Pain

Brief summary

The goal of this clinical trial is to test mindfulness practices in children with idiopathic chest pain, which is chest pain that does not have a known cause. The main question this study aims to answer is whether children who experience idiopathic chest pain are able to follow a mindfulness program. This study also aims to determine whether mindfulness affects the way children with idiopathic chest pain cope, and if it affects their stress levels, quality of life, frequency of chest pain episodes, and chest pain intensity. Participants will: * Complete a survey at the beginning of the study that asks questions about their sex, ethnicity, and history of chest pain and other chronic pains. * Complete a short survey every day for the entirety of the study that asks about the number, intensity, and duration of chest pain episodes experienced that day. * Complete 4 surveys, 2 weeks after they have been enrolled in the study: pain coping survey, perceived stress survey, quality of life survey, and mindfulness survey. * Be randomly placed into either the control group or the mindfulness-based intervention group, 2 weeks after they have been enrolled in the study. * Receive the standard of care for children with idiopathic chest pain, if they are placed into the control group. * Use the mobile app Headspace to complete daily mindfulness sessions for the remaining 30 days of the study (starting after the initial 2 week period), if they are placed in the mindfulness-based intervention group. * Complete 4 surveys at the end of the study: pain coping survey, perceived stress survey, quality of life survey, and mindfulness survey. * Complete a mindfulness program evaluation survey at the end of the study, only if they are in the mindfulness-based intervention group. Researchers will collect information from Headspace to see how well participants in the mindfulness-based intervention group are able to follow the mindfulness program. This will help guide future, larger studies that look at the effects of mindfulness-based interventions in children with idiopathic chest pain. Researchers will also compare survey results between the control group and the mindfulness-based intervention group to see if the mindfulness program affects the way children with idiopathic chest pain cope, as well as their stress levels, quality of life, frequency of chest pain episodes, and chest pain intensity.

Interventions

BEHAVIORALMindfulness-Based Intervention

Participants in the mindfulness-based intervention (MBI) group will be asked to use the Headspace app to sequentially complete the Basics, Basics 2, and Basics 3 courses. Each of these courses lasts 10 days, and participants have the ability to choose how long daily sessions last. Participants can choose between 3, 5, or 10-minute sessions for the Basics course; 10 or 15-minute sessions for the Basics 2 course; and 10, 15, or 20-minute sessions for the Basics 3 course. These daily sessions are audio recordings that prompt users to engage in a variety of mindfulness techniques, including focusing on their body and breathing, as well as acknowledging thoughts and emotions in a non-judgmental manner.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

After a 2-week wash-in period, study participants will be randomly assigned to either the standard of care control group or the mindfulness-based intervention group.

Eligibility

Sex/Gender
ALL
Age
11 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients whose primary complaint is recurrent chest pain that is diagnosed as idiopathic or musculoskeletal by a pediatric cardiologist. * No acute illness. * Normal ECG. * Willing and able to download and use the Headspace application on a daily basis. * Able to complete surveys in the English language.

Exclusion criteria

* Patients whose chest pain is secondary to pericarditis, arrhythmia, or structural heart disease. * Patients with concurrent symptoms that could potentially interfere with the ability to determine the effect on their chest pain (e.g., palpitations or dizziness). * Unable to provide informed assent.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: Survey Response Rate44 daysThe number of surveys completed by participants compared to the number of surveys sent out to be completed.
Feasibility: Participant Recruitment RateBaseline (0 days)The number of patients who consent to participate in the study compared to the number of patients approached about study participation.
Feasibility: Participant Retention Rate44 daysThe number of participants who remain enrolled in the study for the entirety of the study duration compared to the number of participants who consent to participate in the study.
Feasibility: Mindfulness-Based Intervention Program Adherence44 daysData regarding mindfulness-based intervention program adherence will be collected from Headspace. This includes information about all sessions and length of sessions.
Acceptability: Mindfulness-Based Intervention Program Evaluation44 daysData regarding mindfulness-based intervention program evaluation will be collected from the mindfulness program evaluation survey. This survey inquires about duration of the mindfulness program and of daily sessions. It also asks about what participants find most and least useful in the program, as well as what participants want more or less of.

Secondary

MeasureTime frameDescription
Pain Coping Strategies14 days and 44 daysPain coping strategies will be assessed by having participants complete the Pediatric Quality of Life Inventory Pediatric Pain Coping Inventory (PedsQL PPCI). This questionnaire is comprised of 41 items, with scores transformed on a scale from 0 (never) to 2 (often). The minimum score is 0 and the maximum is 82. A higher score indicates a greater use of pain coping strategies.
Perceived Stress14 days and 44 daysPerceived stress will be assessed by having participants complete the Perceived Stress Scale (PSS-10). This questionnaire is comprised of 10 items. The minimum score is 0 and the maximum is 40. A higher score indicates a higher level of perceived stress.
Patient Quality of Life14 days and 44 daysQuality of life will be assessed by having participants complete the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale. This questionnaire is comprised of 23 items which are reverse scored and linearly transformed to a 0-100 scale as follows: 0 (never) = 100 1. (almost never) = 75 2. (sometimes) = 50 3. (often) = 25 4. (almost always) = 0 The minimum score is 0 and the maximum is 2300. A higher score indicates a better health-related quality of life.
Chest Pain Episode FrequencyBegin at 0 days, daily up to 44 daysFrequency of chest pain episodes will be assessed by having participants complete the chest pain episodes survey that inquires about how many chest pain episodes they had that day.
Chest Pain Episode IntensityBegin at 0 days, daily up to 44 daysIntensity of chest pain episodes will be assessed by having participants complete the chest pain episodes survey that inquires about the average intensity of chest pain episodes they had that day. Intensity will be rated using the Wong-Baker FACES Pain Rating Scale.

Countries

Canada

Contacts

Primary ContactSonia Research Associate, PhD
sonia.franciosi@cw.bc.ca604-875-2345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026